vs

Side-by-side financial comparison of MEDIFAST INC (MED) and SILICOM LTD. (SILC). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $61.9M, roughly 1.2× SILICOM LTD.). On growth, SILICOM LTD. posted the faster year-over-year revenue change (6.6% vs -36.9%). SILICOM LTD. produced more free cash flow last quarter ($-3.3M vs $-6.6M).

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

Silicom Ltd. is a publicly traded company, headquartered in Israel, that specializes in the design, manufacture and marketing of connectivity solutions for a range of servers and server-based systems. Its shares are listed on the NASDAQ Global Market and on the Tel Aviv Stock Exchange. Silicom is a member of the RAD Group family of companies.

MED vs SILC — Head-to-Head

Bigger by revenue
MED
MED
1.2× larger
MED
$75.1M
$61.9M
SILC
Growing faster (revenue YoY)
SILC
SILC
+43.5% gap
SILC
6.6%
-36.9%
MED
More free cash flow
SILC
SILC
$3.3M more FCF
SILC
$-3.3M
$-6.6M
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MED
MED
SILC
SILC
Revenue
$75.1M
$61.9M
Net Profit
$-11.5M
Gross Margin
69.4%
30.6%
Operating Margin
-10.4%
-19.8%
Net Margin
-18.5%
Revenue YoY
-36.9%
6.6%
Net Profit YoY
16.3%
EPS (diluted)
$-1.64
$-2.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MED
MED
SILC
SILC
Q4 25
$75.1M
$61.9M
Q3 25
$89.4M
Q2 25
$105.6M
Q1 25
$115.7M
Q4 24
$119.0M
$58.1M
Q3 24
$140.2M
Q2 24
$168.6M
Q1 24
$174.7M
Net Profit
MED
MED
SILC
SILC
Q4 25
$-11.5M
Q3 25
$-2.3M
Q2 25
$2.5M
Q1 25
$-772.0K
Q4 24
$-13.7M
Q3 24
$1.1M
Q2 24
$-8.2M
Q1 24
$8.3M
Gross Margin
MED
MED
SILC
SILC
Q4 25
69.4%
30.6%
Q3 25
69.5%
Q2 25
72.6%
Q1 25
72.8%
Q4 24
74.1%
28.6%
Q3 24
75.4%
Q2 24
73.2%
Q1 24
72.8%
Operating Margin
MED
MED
SILC
SILC
Q4 25
-10.4%
-19.8%
Q3 25
-4.6%
Q2 25
-1.0%
Q1 25
-1.1%
Q4 24
0.6%
-22.8%
Q3 24
1.5%
Q2 24
-4.7%
Q1 24
4.5%
Net Margin
MED
MED
SILC
SILC
Q4 25
-18.5%
Q3 25
-2.5%
Q2 25
2.3%
Q1 25
-0.7%
Q4 24
-23.6%
Q3 24
0.8%
Q2 24
-4.8%
Q1 24
4.8%
EPS (diluted)
MED
MED
SILC
SILC
Q4 25
$-1.64
$-2.01
Q3 25
$-0.21
Q2 25
$0.22
Q1 25
$-0.07
Q4 24
$0.08
$-2.28
Q3 24
$0.10
Q2 24
$-0.75
Q1 24
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MED
MED
SILC
SILC
Cash + ST InvestmentsLiquidity on hand
$167.3M
$42.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$198.9M
$117.5M
Total Assets
$248.0M
$152.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MED
MED
SILC
SILC
Q4 25
$167.3M
$42.1M
Q3 25
$173.5M
Q2 25
$162.7M
Q1 25
$164.6M
Q4 24
$162.3M
$72.1M
Q3 24
$170.0M
Q2 24
$163.5M
Q1 24
$156.4M
Stockholders' Equity
MED
MED
SILC
SILC
Q4 25
$198.9M
$117.5M
Q3 25
$214.7M
Q2 25
$216.0M
Q1 25
$211.0M
Q4 24
$210.1M
$127.8M
Q3 24
$207.3M
Q2 24
$205.3M
Q1 24
$211.0M
Total Assets
MED
MED
SILC
SILC
Q4 25
$248.0M
$152.2M
Q3 25
$268.2M
Q2 25
$269.3M
Q1 25
$280.0M
Q4 24
$284.2M
$150.4M
Q3 24
$291.2M
Q2 24
$293.5M
Q1 24
$302.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MED
MED
SILC
SILC
Operating Cash FlowLast quarter
$-5.3M
$-2.2M
Free Cash FlowOCF − Capex
$-6.6M
$-3.3M
FCF MarginFCF / Revenue
-8.8%
-5.4%
Capex IntensityCapex / Revenue
1.8%
1.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MED
MED
SILC
SILC
Q4 25
$-5.3M
$-2.2M
Q3 25
$12.1M
Q2 25
$-3.4M
Q1 25
$3.4M
Q4 24
$-4.9M
$18.3M
Q3 24
$9.1M
Q2 24
$13.1M
Q1 24
$7.3M
Free Cash Flow
MED
MED
SILC
SILC
Q4 25
$-6.6M
$-3.3M
Q3 25
$10.8M
Q2 25
$-4.8M
Q1 25
$1.9M
Q4 24
$-7.2M
$17.4M
Q3 24
$7.7M
Q2 24
$11.1M
Q1 24
$5.4M
FCF Margin
MED
MED
SILC
SILC
Q4 25
-8.8%
-5.4%
Q3 25
12.0%
Q2 25
-4.5%
Q1 25
1.6%
Q4 24
-6.1%
29.9%
Q3 24
5.5%
Q2 24
6.6%
Q1 24
3.1%
Capex Intensity
MED
MED
SILC
SILC
Q4 25
1.8%
1.9%
Q3 25
1.5%
Q2 25
1.3%
Q1 25
1.3%
Q4 24
1.9%
1.6%
Q3 24
1.0%
Q2 24
1.1%
Q1 24
1.1%
Cash Conversion
MED
MED
SILC
SILC
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
Q3 24
8.04×
Q2 24
Q1 24
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons